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Abstract
 
Many Indian cancer patients who are incurable because of advance stage of the disease 
at the time of diagnosis try various complementary and alternative therapies for treatment 
and palliation. Little is known about the therapeutic efficacy, toxicity and th
potentials of these alternative approaches. In this article I describe a 61 years old male 
patient who presented himself at our clinic with advanced inoperable gastric carcinoma.  
The option of chemotherapy was discussed with the patient and his 
the nature of the disease and the little likelihood of response the patient did not consent 
for the same. The patient opted for an alternative homeopathic therapy to treat his 
cancer. The patient again visited our clinic after one y
was found that though there was no significant change in the gastric mass, but there was 
no evidence of ascites or lymphadenopathy. Liver, gall bladder, spleen, pancreas, both 
kidneys and adrenal appeared normal. There wa
patient and he was able to lead a normal life. I followed the patient for the next one year 
and found that there was no remarkable deterioration in his clinical condition. I feel that it 
may be possible that the alternative homeopathic therapy 
for arresting the cancer progression. 
 
INTRODUCTION 
Despite substantial progress of scientific 
clinical oncology, the fascination of alternative 
and especially complementary cancer medicine 
has not at all declined during past many years. A 
significant proportion of cancer patients 
worldwide use Complementary and Alternative 
Medicine [CAM] (Vicker and Cassileth, 2001). In 
developed countries patients are more likely to 
use complementary therapies to improve the 
quality of their lives in concert with more 
traditional care. Strengthening of the immune 
system is the main goal perhaps reflecting the 
idea that immune system play a major role in 
allowing tumor development and control of 
malignant cells (Morris et al., 2000). In 
developing countries the use of alternative cancer 
therapies are related to socioeconomics and 
cultural / social differences. In many instance the 





Copyright@2013 STAR Journal. All Rights R
 
Sanjoy Kumar Pal 
 
-226014, Uttar Pradesh, India 
 
College of Agriculture and Environmental Sciences, 
 
 
  Article Information
erapeutic 
care givers. In view of 
ear for checkup. On examination it 
s a significant clinical improvement in the 
somehow may be responsible 
 Article History:
 Received  












alternative because of financial constraints, 
inaccessibility to mainstream cancer treatment 
and more importantly late stage incurable 
disease at diagnosis (Pal, 2002a). I report the 
follow-up an advanced stage gastric carcinoma 




A 61 years old male, chronic alcoholic and 
chronic smoker presented with 2 years history of 
abdominal fullness and dyspeptic symptoms, 
waxing and waning in intensity, not progressive 
but aggravated by food intake. The patient h
partial relief in symptoms with proton pump 
inhibitors. There was no history of vomiting, 
constipation, any GI tract bleeding or jaundice. 
He did not have any constitutional symptoms. He 
had mild pallor and pedal edema He did not have 
lymphadenopathy. Abdominal examination 
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showed ill defined mobile lump in epigastrium. 
His investigations revealed hemoglobin 8.4 g/dl; 
total leucocyte count 9300 cells/cmm; platelets 2 
lakhs cells/cmm; ESR 12 per 1
st
 hr; serum 
albumin 2.1 g%; total protein 5.2 g%; ALT 14 
IU/L; AST 24 IU/L; serum alkaline phosphatase 
77 IU/L; conjugated bilirubin 0.4 mg %. His 
esoghago-gastro-duodenoscopy revealed a 2 x 
1.5 cm ulcerated friable growth in the deformed 
pylorus from which biopsy was taken. The CECT 
abdomen revealed circumferential asymmetric 
growth in antro-pyloric region with extension into 
duodenum, with no evidence of ascites, 
lymphadenopathy and liver metastasis (Figure 1). 
Histopathology examination of the growth 
showed moderate to poorly differentiated 
adenocarcinoma. With the diagnosis of locally 
advanced gastric carcinoma exploratory 
laprotomy was done, however, the patient was 
found to have moderate ascites and the growth 
had infiltrated into D1, hepatoduodenal ligament, 
mesocolon and pancreas. Stomach wall was 
dilated and thickened. However, there was no 
evidence of liver metastasis or dissemination. 
Gastrojejunostomy was done and a feeding 
nasojejunal tube was placed. Initial post operative 
recovery was satisfactory; nasojejunal tube was 
removed on post operative day 6. Blood 
transfusion 2 units was given due to low 
haemoglobin, on post operative day 8 patient 
developed jaundice which was found to be 
transfusion related and subsided spontaneously. 
The patient had hiccups and abdominal fullness 
on oral intake. Ryle’s tube was placed which 
showed high output 1000 – 2000 ml/day, bilious 
in nature. Upper GI endoscopy did not revealed 
any evidence of mechanical obstruction to 
gastrojejunal stroma. Patient was again allowed 
oral intake which he tolerated. On postoperative 
day 13 patient had haematemesis (coffee 
ground) with 3 episode of melana, may be from 
tumoural bleeding, he was managed 
conservatively with blood transfusions. Gradually, 
the oral intake improved and the patient was 
discharged. The option of chemotherapy was 
discussed with the patient and his care givers. In 
view of the nature of the disease and the small 
likelihood of response the patient did not 
consented for the same, instead he wanted to try 
a homeopathic cancer therapy called ‘Psorinum’ 
advocated by Dr. Ashim Chatterjee. This 
alternative therapy is a combination of 
homeopathic mother tinctures with conventional 
life support care. This approach is very popular 
among terminal cancer patient in Kolkata (Pal, 
2002a). 
 
One year after this incidence the patient 
reported in our out patient clinic for follow-up. On 
examination it was found that though there was 
no significant change in the gastric mass, but 
there was no evidence of ascites or 
lymphadenopathy. Liver, gall bladder, spleen, 
pancreas, both kidneys and adrenal appeared 
normal. There was a significant clinical 
improvement in the patient and he was able to 
lead a normal life. He did not stop smoking, but 
restricted his alcohol intake. He responded well to 
homeopathic medicines and did not have any 
adverse side effect. I followed the patients for 
another one year; and found that there was no 
remarkable deterioration in his clinical conditions. 
However, along with the homeopathic therapy the 
patient also took liver stimulants and vitamins, but 
no chemotherapy or any other kind of alternative 
therapy.
 












                                   Figure 1: Abdominal CT Scan of the patients at presentation. 





Cancer of the gastro-intestinal tract remains a 
major challenge to surgical, medical and radiation 
oncologists. Many of these tumors are not 
respectable at the time of presentation as a result 
palliative treatment is the only option. Of the 
million people who get cancer every year in India, 
the vast majority is incurable at the time of 
diagnosis (Jones, 1999). In hope to leave no 
stone unturned many terminal ill cancer patient 
turn to Alternative Cancer Therapy (ACT) for 
making last-ditch effort to fine cure. In this 
situation the patients become more susceptible to 
quackery, risk emotional distress, false hope, and 
wasted money. However, there are remarkable 
anecdotal reports of survival benefits in cancer 
patients treated with ACT which needs attention. 
The Psorinum therapy is one such alternative 
approach that has become quite popular among 
cancer patients due to its effectiveness in 
improving the quality of life, survival benefits and 
is associated with fewer side effects (Chatterjee 
et al., 2005). This therapy is based on individual 
dosing of homeopathic mother tinctures for each 
patient (Chatterjee et al., 2011). Complete 
regression of cancer with this alternative therapy 
has also been observed in many patients 
(Chatterjee and Biswas, 2012). I believe that the 
alternative homeopathic therapy may have been 
responsible for stabilizing the disease of the 
patient I described. 
  
The increase popularity of CAM is now well 
documented. The use of CAM by the American 
public increased from 34% in 1990 to 42% in 
1995 (Cassileth, 2002). In a survey by Morris et 
al., (2000), it was found that 75% of the breast 
cancer patients of USA used complementary 
modality to treat their cancer. CAM is immensely 
popular in Australia, Canada, China, and Europe 
especially in Germany (Pal, 2002b). The Users of 
CAM are young, of high social class, likely to be 
female, tend to be more health conscious and will 
spend out of pocket (Cassileth, 2002). However, 
it is difficult to accommodate the individualized 
orientation of CAM therapies to the 
standardization of clinical trials. Hence, 
evaluation of potential safe and efficacious 
nontoxic therapies is ‘orphaned’ as they are not 
patentable and cannot be integrated into main 
stream medicine. Evidence-based strategies to 
distinguish useful from useless interventions are 
now experimented.  
 
Homeopathy had a prominent place in 19
th
 
century health care and has recently undergone a 
worldwide revival (Jones et al., 2003). 
Homeopathic medicines are very popular among 
patients with cancer in Europe (van der Weg and 
Streuli, 2003). On average 30% of referrals made 
to the Homeopathic Hospitals within the UK come 
directly from oncologists (Thompson and Reilly, 
2002). The area of symptom management is one 
where homeopathy may offer a gentler holistic 
approach to alleviating symptom (Clover et al., 
1995). There is also evidence from randomized 
controlled trials that homeopathy may be effective 
for the treatment of influenza, allergies, post 
operative ileus, and childhood diarrhea (Jones et 
al., 2003). Until homeopathy is better understood, 
it is important that physicians be open-minded 
about homeopathy’s possible value and maintain 
communication with patients who use it. 
 
Despite successful advances in the 
management of some cancer, half of all patients 
currently diagnosed with cancer will die of their 
disease within a few years (Higginson and Finlay, 
2003). Cancer burden is also set to increase with 
the aging population and by 2020 this number is 
expected to increase to 20 million (Sansom and 
Mutuma, 2002). Perhaps disturbingly, 70% of 
people are thought to live in the developing world. 
We do not yet have an effective means for either 
primary or secondary prevention of most 
malignant visceral tumor types. Hence, most 
treatment approaches in adult cancer patients are 
‘palliative’ directed to prevent and treat 
unnecessary suffering of these patients on their 
way to premature death (Senn, 2001). Until there 
is a dramatic improvement in cancer mortality 
using conventional treatment, CAM will continue 
to attract many cancer patients. With high 
propensity for late-stage diagnosis, and in 
situation when cure is no longer the realistic 
objective, it is possible that CAM approaches like 
homeopathy may play an important role. Proper 
coordination between CAM provider and 
conventional clinicians are therefore required so 
that effective therapies are documented and can 
be offered to other patients. About 50% of the 
world’s cancer burden is carried by developing 
countries that ironically have limited resources 
available to fight the disease. Evidence based 
CAM if integrated properly in to mainstream 
medicine may play an important role in palliative 
care in developing countries. 
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